助手标题  
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
   chronic asthmatic bronchitis 的翻译结果: 查询用时:0.199秒
图标索引 在分类学科中查询
所有学科
呼吸系统疾病
中医学
内分泌腺及全身性疾病
中西医结合
更多类别查询

图标索引 历史查询
 

chronic asthmatic bronchitis     
相关语句
  慢性喘息型支气管炎
     CLINICAL SIGNIFICANCE OF DETERMINATION OF PLASA GMP-140 LEVELS IN PATIENTS WITH CHRONIC ASTHMATIC BRONCHITIS
     血浆GMP-140测定在慢性喘息型支气管炎患者中的临床意义
短句来源
     The changes of chemiluminescence of peripheral neutrophil in chronic asthmatic bronchitis patients and the effect of M_2 on it
     慢性喘息型支气管炎患者外周血中性粒细胞化学发光的改变及M_2对其的影响
短句来源
     By double antibody sandwich-solid phase radioimmunoassay method, plasma GMP-140 levels in chronic asthmatic bronchitis (CBA) patients were determined for studying the change of adhesion molecules in CBA.
     应用双抗体夹心、固相免疫放射分析法(IRMA)对46例慢性喘息型支气管炎(慢喘支)患者血浆α-颗粒膜蛋白(GMP-140)进行检测,以探讨粘附分子在慢喘支患者血浆中的变化及意义。
短句来源
     Methods The budesonide asthmatic,2~3 time each day,1~2 puffs each time,for one month was used in 49 patients with chronic asthmatic bronchitis,the clinical symptom, pulmonary function and arterial blood gas analysis were observed.
     方法49例慢性喘息型支气管炎应用布地奈德气雾剂,每日2~3次,每次1~2喷吸入,连续使用1个月,观察患者临床症状、肺功能、动脉血气等改善情况。
短句来源
     Objective: Observing the clinical effect of medicinal cupping treating chronic asthmatic bronchitis in the protracted course, we explored its partial mechanism from molecular immunology aspect.
     目的:观察药罐疗法治疗慢性喘息型支气管炎迁延期的临床疗效,对药罐疗法治疗慢性喘息型支气管炎迁延期的现代医学机制进行初步探讨。
短句来源
更多       
  慢性喘息性支气管炎
     Method 31 patients with chronic asthmatic bronchitis were treated by taking protheo 400 mg once a day orally for 6 weeks.
     方法对31例慢性喘息性支气管炎患者使用Protheo每日一次400mg口服,连续治疗6周。
短句来源
     Methods 51 patients with chronic asthmatic bronchitis were separated into two groups,one group with PaCO 2≤6 0 kPa and the other with PaCO 2>6 0 kPa,and then retrospective analyses were made for the two groups.
     方法将临床诊断为慢性喘息性支气管炎(慢喘支)的51例,按入院时PaCO2为6.0kPa作为界限值进行分组,分别收集临床资料作回顾性分析。
短句来源
     This paper reports the results of scopolamine in the patients with pulmonary emcephalopthy (17 cases), chronic asthmatic bronchitis (14 cases) and bronchial asthma (6 cases).
     本文报告东莨菪碱治疗肺性脑病,慢性喘息性支气管炎,支气管哮喘37例,其中肺脑17例,慢支14例,哮喘6例. 结果:肺脑中重型用东莨菪碱0.3mg—3 mg为显著镇静作用.
短句来源
     60 Cases with Chronic Asthmatic Bronchitis in the Relieve Asthma Prescription
     平哮方治疗慢性喘息性支气管炎60例
短句来源
     Methods 33 patients in exacerbations with chronic bronchitis (CB group),chronic asthmatic bronchitis (CAB group) and bronchial asthma (BA group) (11 cases respectively) and 7 healthy volunteers as controls (C group) have participated in lung function test and sputum induction.
     方法 收集单纯型慢性支气管炎 (A组 )、慢性喘息性支气管炎 (B组 )、支气管哮喘 (C组 )急性发作期患者各 11例和健康对照者 (D组 ) 7名。
短句来源
更多       
  喘息型慢性支气管炎
     Clinical Observation on the Treatment of Chronic Asthmatic Bronchitis with Chuanxining Decoction(喘息宁汤),a Report of 60 Cases
     喘息宁汤治疗喘息型慢性支气管炎60例临床观察
短句来源
     Effects of Injection Salviae Miltiorrhizae on Senile Chronic Asthmatic Bronchitis Patients
     丹参注射液治疗老年喘息型慢性支气管炎33例临床观察
短句来源
     Furthermore,the outcome of examination displayed that thepatients with chronic asthmatic bronchitis could be divided in twogroups, the high levels of ECP and tryptase in the first group and thecontrary in the second group, so that a conclusion could be drawn that apart of patients with chronic asthmatic bronchitis has the same nature ofasthmatics.
     本研究还分析了喘息型慢性支气管炎诱导疾的特征,结果显示喘息型慢性支气管炎患者可以分为两组,一组ECP、类胰蛋白酶(Tryptase)浓度均较高,另一组则相反,提示喘息型慢性支气管炎患者中一部分实为哮喘急性发作。
短句来源
     Sixty cases of chronic asthmatic bronchitis were treated with Chuanxining Decoction(CD),30 cases treated with Xiansheng Kechuanning Oral Liquid(XKOL).
     采用喘息宁汤治疗喘息型慢性支气管炎 (肺气虚 ) 6 0例 ,并随机与先声咳喘宁口服液组 30例作对照。
短句来源
  慢性支气管炎喘息型
     A clinical investigation of treatment of chronic asthmatic bronchitis with meglumine cyclic adenglote in 58 patients
     心先安(环磷酸腺苷葡甲胺)治疗慢性支气管炎喘息型58例临床观察
短句来源
     Clinical observation on Jinshuiliujun decoction in treating 56 cases of chronic asthmatic bronchitis in acute attack period
     金水六君煎治疗慢性支气管炎喘息型急性发作期56例疗效观察
短句来源
     Objective To observe the therapeutic effect of Jinshuiliujun decoction on chronic asthmatic bronchitis in acute attack period.
     目的 观察金水六君煎治疗慢性支气管炎喘息型急性发作期的临床疗效。
短句来源
     Methods 102 patients with chronic asthmatic bronchitis in acute attack period were randomly divided into two groups. 56 patients in treatment group were treated with Jinshuiliujun decoction, decocted in water for oral dose, one dose daily;
     方法  10 2例慢性支气管炎喘息型急性发作期患者随机分为 2组 ,治疗组 5 6例给予金水六君煎 ,每日 1剂 ,水煎服 ;
短句来源
     Conclusion Jinshuiliujun decoction is effective in treating chronic asthmatic bronchitis in acute attack period, which can improve the clinical symptoms fast and shorten the treatment course, without side effect.
     结论 金水六君煎治疗慢性支气管炎喘息型急性发作期能迅速改善症状 ,缩短疗程 ,无毒副作用 ,提高临床疗效。
短句来源

 

查询“chronic asthmatic bronchitis”译词为其他词的双语例句

 

查询“chronic asthmatic bronchitis”译词为用户自定义的双语例句

    我想查看译文中含有:的双语例句
例句
为了更好的帮助您理解掌握查询词或其译词在地道英语中的实际用法,我们为您准备了出自英文原文的大量英语例句,供您参考。
  chronic asthmatic bronchitis
Haemophilus influenzae is a bacterium that often can be isolated from the deeper respiratory airways of patients with chronic asthmatic bronchitis.
      
We describe the case of a 60-year-old man with an history of chronic asthmatic bronchitis admitted for status asthmaticus.
      


This paper reports the results of scopolamine in the patients with pulmonary emcephalopthy (17 cases), chronic asthmatic bronchitis (14 cases) and bronchial asthma (6 cases).

本文报告东莨菪碱治疗肺性脑病,慢性喘息性支气管炎,支气管哮喘37例,其中肺脑17例,慢支14例,哮喘6例.结果:肺脑中重型用东莨菪碱0.3mg—3 mg为显著镇静作用.慢支及哮喘用0.3—0.9mg平喘显效11例,有效7例,无效2例.

The effects of nifedipine on lung ventilatory function were observed in 40 patients with bronchial asthma and 10 patients with chronic asthmatic bronchitis.The results showed that FVC was significantly increased from 10 to 120 minutes after sublingual administration of nifedipine(20mg) in the asthma group(P<0.01),and from 10 to 30 minutes after sublingual administration in the chronic bronchitis group(p<0.05).FEVV_1 began to increase at the 30th minute after sublingual administration and reached...

The effects of nifedipine on lung ventilatory function were observed in 40 patients with bronchial asthma and 10 patients with chronic asthmatic bronchitis.The results showed that FVC was significantly increased from 10 to 120 minutes after sublingual administration of nifedipine(20mg) in the asthma group(P<0.01),and from 10 to 30 minutes after sublingual administration in the chronic bronchitis group(p<0.05).FEVV_1 began to increase at the 30th minute after sublingual administration and reached the peak at the 60th minute in the asthma group;but in the chronic asthmatic bronchitis group,increase in FEV_1 occurred at the 60th minute and reached the peak at the second hour.In the bronchial asthma patients of FEV_1>35% prediction value,both FVC and FEV_1 more significantlyincreased after sublingual administration as compared with the patients of FEV_1<35% prediction value.The results suggest that nifedipine has obvious effects on the patients with bronchial asthma,especially in mild attack.

对50例支气管哮喘(哮喘)及喘息型支气管炎(喘支)患者,喘息发作时,舌下含化硝苯啶20mg后,120分钟内连续观察肺功能的改变。结果表明,哮喘组在含药后10~120分钟FVC显著增加(P<0.01),喘支组于10~30分钟FVC显著增加(P<0.05),120分钟达高峰(P<0.01)。哮喘组FEV_1于30分钟开始增加,60分钟达高峰(P<0.01),而喘支组于60分钟开始增加,120分钟达高峰。说明哮喘组的肺通气功能较喘支组改善明显。在哮喘组中,FEV_1>35%预计值组,于含药后FVC及FEV_1均显著增加,而FEV_1<35%预计值组,只有FVC的增加。说明硝苯啶含化对哮喘发作病人,特别是病情较轻的病人效果更佳。

36 Patients with bronchial asthma and chronic asthmatic bronchitis were treated with β_2-receptor agonists and theophyUine drugs. The Change of plasma potassium level were observed in K~+—treated group and not treated group before and after the treatment. It was found that after the treatment the plasma potassium level were reduced to certain degree in both groups. The Reduction was more obvious in the group without potassium supplied in which the difference before and after treatment was very Significant...

36 Patients with bronchial asthma and chronic asthmatic bronchitis were treated with β_2-receptor agonists and theophyUine drugs. The Change of plasma potassium level were observed in K~+—treated group and not treated group before and after the treatment. It was found that after the treatment the plasma potassium level were reduced to certain degree in both groups. The Reduction was more obvious in the group without potassium supplied in which the difference before and after treatment was very Significant (P<0.01). But in the potassium supplied group the difference was not Significant (P>0.05). It was suggested that potassium chloride should beused as bronchodilator.

对支气管哮喘与喘息型慢性支气管炎住院患者36例,合用β_2受体激动剂与茶碱类制剂治疗,对比观察了用药前后补钾组与未补钾组血清钾浓度的变化,发现两组病人治疗后血清钾浓度均较治疗前有一定程度的降低,未补钾组降低程度显著,前后比较有非常显著性差异(P<0.01);但补钾组前后比较无显著性差异(P>0.05)。

 
<< 更多相关文摘    
图标索引 相关查询

 


 
CNKI小工具
在英文学术搜索中查有关chronic asthmatic bronchitis的内容
在知识搜索中查有关chronic asthmatic bronchitis的内容
在数字搜索中查有关chronic asthmatic bronchitis的内容
在概念知识元中查有关chronic asthmatic bronchitis的内容
在学术趋势中查有关chronic asthmatic bronchitis的内容
 
 

CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社